Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated,

Li-Hua Chen1, Jing Fang, Huaixing Li

  • 1Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, and Graduate School of the Chinese Academy of Sciences, Shanghai, China.

Insights

Enterolactone, a metabolite of plant lignans, selectively kills prostate cancer cells by inducing apoptosis. This process involves mitochondrial dysfunction and caspase activation, suggesting its potential as a cancer preventive agent.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Enterolactone is a mammalian lignan metabolite derived from plant lignans.
  • Enterolactone has demonstrated inhibitory effects on prostate cancer growth and development.
  • The precise mechanisms underlying enterolactone's anticancer activity remain largely unelucidated.

Purpose of the Study:

  • To investigate the mechanistic basis of enterolactone's selective suppression of prostate cancer cell growth.
  • To elucidate the role of apoptosis in enterolactone's anticancer effects.
  • To identify key molecular players involved in enterolactone-induced apoptosis.

Main Methods:

  • Utilized LNCaP prostate cancer cells to assess enterolactone's effects.
  • Quantified mitochondrial membrane potential and cytochrome c release.
  • Analyzed procaspase-3 and poly(ADP-ribose)-polymerase (PARP) cleavage.
  • Employed a pan-caspase inhibitor (z-VAD-fmk) to confirm caspase dependence.
  • Investigated the involvement of signaling pathways including Akt, GSK-3beta, MDM2, and p53.

Main Results:

  • Enterolactone selectively inhibited the growth of LNCaP prostate cancer cells.
  • Enterolactone triggered apoptosis, evidenced by dose-dependent mitochondrial membrane potential loss and cytochrome c release.
  • Cleavage of procaspase-3 and PARP confirmed apoptosis induction.
  • Enterolactone-mediated apoptosis was caspase-dependent.
  • Akt, GSK-3beta, MDM2, and p53 were implicated in the apoptotic process.

Conclusions:

  • Enterolactone induces apoptosis in prostate cancer cells via mitochondrial pathways and caspase activation.
  • The study identifies key molecular mediators of enterolactone's action.
  • Enterolactone shows promise as a chemopreventive agent for prostate cancer, warranting further investigation.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...